Before Health Intelligence, Ltd. has announced the development of Antshrike™, a mobile health application that uses artificial intelligence to predict heart attacks and strokes by processing biometric data from Apple smart phones and smart watches. Cardiovascular disease remains the leading cause of death worldwide, making the potential impact of this technology particularly significant for preventive healthcare. The app aims to provide early warnings of critical cardiovascular events with personalized, real-time risk assessments that could enable timely medical interventions.
The technology behind Antshrike™ incorporates data from over 130 billion data points and CDC information from tens of thousands of individuals, resulting in predictive accuracy of over 85% for cardiovascular events. This statistic could significantly alter the landscape of heart disease management by providing users with actionable insights into their cardiovascular risk. One key feature is the app's ability to passively monitor health status without disrupting daily routines, using a non-intrusive approach that could lead to wider adoption and more consistent use in preventive care.
Privacy concerns have been addressed through HIPAA-compliant preprocessing of data on the user's device, ensuring sensitive health information remains protected while still allowing for powerful predictive capabilities. The AI technology operates on two levels: a static layer that processes user-input data to determine an initial risk score, and a dynamic layer that analyzes real-time biometric data from smart watches. This dual-layer approach allows for comprehensive assessment of an individual's cardiovascular health, considering both long-term factors and immediate physiological changes.
Dr. Ekaterina Mitricheva, CEO and co-founder of Before Health Intelligence, emphasized the urgency behind the app's development, noting cardiovascular disease as the number one cause of death worldwide. The name 'Antshrike,' inspired by a South American bird known for warning primates of danger, reflects the app's purpose in alerting users to potential health risks. For healthcare providers, Antshrike™ represents a valuable tool that could allow for more timely interventions, potentially reducing the severity of cardiovascular events or preventing them entirely.
The app's freemium model, set to launch in the U.S. in 2025, could make this technology accessible to a wide range of users as wearable technology becomes increasingly prevalent. The development underscores the growing intersection of artificial intelligence and healthcare, with applications in medical diagnostics and predictive health likely to expand. The success of Antshrike™ could pave the way for similar AI-driven applications targeting other complex diseases, further enhancing our ability to predict and prevent serious health events. For more information about Antshrike™ and its capabilities, interested parties can visit https://www.beforehealthintelligence.com.
